MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal...